Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

Clinical trial NCT01394029 · COMPLETED

Trial details

NCT number: NCT01394029
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Transfusional Hemosiderosis

Start date: 2011-07-01
Primary completion: 2015-10-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.